XML 34 R23.htm IDEA: XBRL DOCUMENT v3.21.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Schedule of Stock-based Compensation Expense for Employees and Non-employees

In the accompanying condensed consolidated statements of operations, the Company recognized stock-based compensation expense for its employees and non-employees as follows:

 

 

 

Three Months Ended

March 31,

 

 

 

2021

 

 

2020

 

 

 

(in thousands)

 

Research and development

 

$

1,663

 

 

$

546

 

General and administrative

 

 

1,268

 

 

 

372

 

Total stock-based compensation

 

$

2,931

 

 

$

918

 

Schedule of Estimated Grant-date Fair Value of Stock-based Awards Using Black-Scholes Option Pricing Model Assumptions

 

 

 

Three Months Ended

March 31,

 

 

 

2021

 

 

2020

 

Expected term (in years)

 

5.5 – 7.0

 

 

5.7 – 6.7

 

Expected volatility

 

 

84 – 85

%

 

 

88 – 90

%

Risk-free interest rate

 

 

0.5 – 1.1

%

 

 

0.6 – 1.2

%

Expected dividend rate

 

 

%

 

 

%

 

Summary of Stock-Based Compensation Activity

A summary of activity under the 2008 Plan, 2015 Plan and 2018 Plan and related information is as follows:

 

 

 

 

 

 

 

Options Outstanding

 

 

 

Shares

Available

for Grant

 

 

Number

of Shares

Outstanding

 

 

Weighted-

Average

Exercise

Price Per

Share

 

 

Weighted-

Average

Remaining

Contractual

Term

(Years)

 

 

Aggregate

Intrinsic

Value of

Outstanding

Options

(in thousands)

 

Outstanding — December 31, 2020

 

 

1,117,796

 

 

 

4,146,928

 

 

$

19.45

 

 

 

8.84

 

 

$

12,227

 

Awards authorized

 

 

945,139

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options granted

 

 

(650,460

)

 

 

650,460

 

 

 

16.52

 

 

 

 

 

 

 

 

 

Options exercised

 

-

 

 

 

(21,662

)

 

 

13.28

 

 

 

 

 

 

 

 

 

Options forfeited/cancelled

 

 

108,553

 

 

 

(108,553

)

 

 

14.72

 

 

 

 

 

 

 

 

 

Outstanding — March 31, 2021

 

 

1,521,028

 

 

 

4,667,173

 

 

$

19.18

 

 

8.76

 

 

$

16,794

 

Exercisable — March 31, 2021

 

 

 

 

 

 

755,413

 

 

$

46.18

 

 

5.66

 

 

$

1,905

 

Vested and expected to vest — March 31, 2021

 

 

 

 

 

 

4,131,935

 

 

$

20.09

 

 

8.67

 

 

$

14,075